These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 23474666

  • 1. FEV6 assessment in spirometric abnormalities screening: the first population-based study in Italian pharmacies.
    Solidoro P, Braido F, Baratta F, Bagnasco D, Esposito R, Aggeri M, Brusa P.
    Panminerva Med; 2013 Mar; 55(1):87-92. PubMed ID: 23474666
    [Abstract] [Full Text] [Related]

  • 2. COPD case finding by spirometry in high-risk customers of urban community pharmacies: a pilot study.
    Castillo D, Guayta R, Giner J, Burgos F, Capdevila C, Soriano JB, Barau M, Casan P, FARMAEPOC group.
    Respir Med; 2009 Jun; 103(6):839-45. PubMed ID: 19200706
    [Abstract] [Full Text] [Related]

  • 3. The objective evaluation of obstructive pulmonary diseases with spirometry.
    Ozkaya S, Dirican A, Tuna T.
    Int J Chron Obstruct Pulmon Dis; 2016 Jun; 11():2009-15. PubMed ID: 27616884
    [Abstract] [Full Text] [Related]

  • 4. VitalQPlus: a potential screening tool for early diagnosis of COPD.
    Sui CF, Ming LC, Neoh CF, Ibrahim B.
    Int J Chron Obstruct Pulmon Dis; 2015 Jun; 10():1613-22. PubMed ID: 26316735
    [Abstract] [Full Text] [Related]

  • 5. FEV1/FEV6 and FEV6 as an alternative for FEV1/FVC and FVC in the spirometric detection of airway obstruction and restriction.
    Vandevoorde J, Verbanck S, Schuermans D, Kartounian J, Vincken W.
    Chest; 2005 May; 127(5):1560-4. PubMed ID: 15888828
    [Abstract] [Full Text] [Related]

  • 6. Cut-off value of FEV1/FEV6 as a surrogate for FEV1/FVC for detecting airway obstruction in a Korean population.
    Chung KS, Jung JY, Park MS, Kim YS, Kim SK, Chang J, Song JH.
    Int J Chron Obstruct Pulmon Dis; 2016 May; 11():1957-63. PubMed ID: 27578970
    [Abstract] [Full Text] [Related]

  • 7. Prevalence of undiagnosed airflow obstruction among people with a history of smoking in a primary care setting.
    Fu SN, Yu WC, Wong CK, Lam MC.
    Int J Chron Obstruct Pulmon Dis; 2016 May; 11():2391-2399. PubMed ID: 27729780
    [Abstract] [Full Text] [Related]

  • 8. Obstructive and restrictive spirometric patterns: fixed cut-offs for FEV1/FEV6 and FEV6.
    Vandevoorde J, Verbanck S, Schuermans D, Kartounian J, Vincken W.
    Eur Respir J; 2006 Feb; 27(2):378-83. PubMed ID: 16452596
    [Abstract] [Full Text] [Related]

  • 9. Comparison of FEV6 and FVC for detection of airway obstruction in a community hospital pulmonary function laboratory.
    Gleeson S, Mitchell B, Pasquarella C, Reardon E, Falsone J, Berman L.
    Respir Med; 2006 Aug; 100(8):1397-401. PubMed ID: 16388944
    [Abstract] [Full Text] [Related]

  • 10. [FEV1 after three years of observation in patients with bronchial asthma and patients with chronic obstructive pulmonary disease].
    Zagdańska R, Grzelewska-Rzymowska I.
    Pneumonol Alergol Pol; 2005 Aug; 73(2):142-7. PubMed ID: 16756143
    [Abstract] [Full Text] [Related]

  • 11. Voluntary lung function screening to reveal new COPD cases in southern Italy.
    Capozzolo A, Castellana G, Dragonieri S, Carratù P, Liotino V, Vulpi MR, Marra L, Resta E, Intiglietta P, Resta O.
    Int J Chron Obstruct Pulmon Dis; 2017 Aug; 12():2035-2042. PubMed ID: 28744118
    [Abstract] [Full Text] [Related]

  • 12. Obstructive lung diseases: COPD, asthma, and many imitators.
    Ryu JH, Scanlon PD.
    Mayo Clin Proc; 2001 Nov; 76(11):1144-53. PubMed ID: 11702903
    [Abstract] [Full Text] [Related]

  • 13. Six-second spirometry for detection of airway obstruction: a population-based study in Austria.
    Lamprecht B, Schirnhofer L, Tiefenbacher F, Kaiser B, Buist SA, Studnicka M, Enright P.
    Am J Respir Crit Care Med; 2007 Sep 01; 176(5):460-4. PubMed ID: 17556719
    [Abstract] [Full Text] [Related]

  • 14. Multicenter study of the COPD-6 screening device: feasible for early detection of chronic obstructive pulmonary disease in primary care?
    Kjeldgaard P, Lykkegaard J, Spillemose H, Ulrik CS.
    Int J Chron Obstruct Pulmon Dis; 2017 Sep 01; 12():2323-2331. PubMed ID: 28831249
    [Abstract] [Full Text] [Related]

  • 15. The relationship between the COPD Assessment Test score and airflow limitation in Japan in patients aged over 40 years with a smoking history.
    Yoshimoto D, Nakano Y, Onishi K, Hagan G, Jones P.
    Int J Chron Obstruct Pulmon Dis; 2014 Sep 01; 9():1357-63. PubMed ID: 25525353
    [Abstract] [Full Text] [Related]

  • 16. Assessing small airway disease in GLI versus NHANES III based spirometry using area under the expiratory flow-volume curve.
    Ioachimescu OC, Stoller JK.
    BMJ Open Respir Res; 2019 Sep 01; 6(1):e000511. PubMed ID: 31803477
    [Abstract] [Full Text] [Related]

  • 17. Community pharmacy-based case finding for COPD in urban and rural settings is feasible and effective.
    Fathima M, Saini B, Foster JM, Armour CL.
    Int J Chron Obstruct Pulmon Dis; 2017 Sep 01; 12():2753-2761. PubMed ID: 29075108
    [Abstract] [Full Text] [Related]

  • 18. Lung volume abnormalities and its correlation to spirometric and demographic variables in adult asthma.
    Jain VV, Abejie B, Bashir MH, Tyner T, Vempilly J.
    J Asthma; 2013 Aug 01; 50(6):600-5. PubMed ID: 23521185
    [Abstract] [Full Text] [Related]

  • 19. The diagnostic importance of a reduced FEV1/FEV6.
    Morris ZQ, Huda N, Burke RR.
    COPD; 2012 Feb 01; 9(1):22-8. PubMed ID: 22292595
    [Abstract] [Full Text] [Related]

  • 20. Asthma masquerading as chronic obstructive pulmonary disease: a study of smokers fulfilling the GOLD definition of chronic obstructive pulmonary disease.
    Al-Kassimi FA, Abba AA, Al-Hajjaj MS, Alhamad EH, Raddaoui E, Shaikh SA.
    Respiration; 2011 Feb 01; 82(1):19-27. PubMed ID: 21282939
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.